Literature DB >> 32992344

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.

Andreas Agathangelidis1, Anastasia Chatzidimitriou1,2, Katerina Gemenetzi1,3, Veronique Giudicelli4, Maria Karypidou1, Karla Plevova5,6, Zadie Davis7, Xiao-Jie Yan8, Sabine Jeromin9, Christof Schneider10, Lone Bredo Pedersen11, Renee C Tschumper12, Lesley-Ann Sutton2, Panagiotis Baliakas13, Lydia Scarfò14, Ellen J van Gastel15, Marine Armand16, Eugen Tausch17, Bella Biderman18, Constance Baer9, Davide Bagnara19, Alba Navarro20,21, Anne Langlois de Septenville16, Valentina Guido22, Gerlinde Mitterbauer-Hohendanner23, Aleksandar Dimovski24, Christian Brieghel11, Sarah Lawless25, Manja Meggendorfer9, Kamila Brazdilova5,6, Matthias Ritgen26, Monica Facco27,28, Cristina Tresoldi29, Andrea Visentin27,28, Andrea Patriarca30, Mark Catherwood25, Lisa Bonello31, Andrey Sudarikov18, Katrina Vanura23, Maria Roumelioti32, Hana Skuhrova Francova5, Theodoros Moysiadis1, Silvio Veronese22, Krzysztof Giannopoulos33, Larry Mansouri2, Teodora Karan-Djurasevic34, Raphael Sandaltzopoulos3, Csaba Bödör35, Franco Fais19,36, Arnon P Kater37, Irina Panovska38, Davide Rossi39, Salem Alshemmari40, Panagiotis Panagiotidis32, Paul Costeas41,42, Blanca Espinet43, Darko Antic44, Letizia Foroni45, Marco Montillo22, Livio Trentin27,28, Niki Stavroyianni46, Gianluca Gaidano30, Paola Francia di Celle31, Carsten Niemann11, Elias Campo20,21,47, Achilles Anagnostopoulos45, Christiane Pott26, Kirsten Fischer48, Michael Hallek49, David Oscier7, Stephan Stilgenbauer17, Claudia Haferlach9, Diane Jelinek50, Nicholas Chiorazzi8, Sarka Pospisilova5,6, Marie-Paule Lefranc4, Sofia Kossida4, Anton W Langerak15, Chrysoula Belessi51, Frederic Davi15, Richard Rosenquist2,52, Paolo Ghia14, Kostas Stamatopoulos1,2.   

Abstract

Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain major stereotyped subsets often display remarkably consistent clinicobiological profiles, suggesting that the study of BcR immunoglobulin stereotypy in CLL has important implications for understanding disease pathophysiology and refining clinical decision-making. Nevertheless, several issues remain open, especially pertaining to the actual frequency of BcR immunoglobulin stereotypy and major subsets, as well as the existence of higher-order connections between individual subsets. To address these issues, we investigated clonotypic IGHV-IGHD-IGHJ gene rearrangements in a series of 29 856 patients with CLL, by far the largest series worldwide. We report that the stereotyped fraction of CLL peaks at 41% of the entire cohort and that all 19 previously identified major subsets retained their relative size and ranking, while 10 new ones emerged; overall, major stereotyped subsets had a cumulative frequency of 13.5%. Higher-level relationships were evident between subsets, particularly for major stereotyped subsets with unmutated IGHV genes (U-CLL), for which close relations with other subsets, termed "satellites," were identified. Satellite subsets accounted for 3% of the entire cohort. These results confirm our previous notion that major subsets can be robustly identified and are consistent in relative size, hence representing distinct disease variants amenable to compartmentalized research with the potential of overcoming the pronounced heterogeneity of CLL. Furthermore, the existence of satellite subsets reveals a novel aspect of repertoire restriction with implications for refined molecular classification of CLL.
© 2021 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32992344      PMCID: PMC7976441          DOI: 10.1182/blood.2020007039

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  78 in total

1.  The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells.

Authors:  Francesco Forconi; Kathleen N Potter; Elisa Sozzi; Isla Henderson; Emanuele Cencini; Davide Rossi; Riccardo Bomben; Valter Gattei; Gianluca Gaidano; Graham Packham; Freda K Stevenson
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

2.  Immune thrombocytopenia in patients with chronic lymphocytic leukemia is associated with stereotyped B-cell receptors.

Authors:  Carlo Visco; Francesco Maura; Giacomo Tuana; Luca Agnelli; Marta Lionetti; Sonia Fabris; Elisabetta Novella; Ilaria Giaretta; Gianluigi Reda; Wilma Barcellini; Luca Baldini; Antonino Neri; Francesco Rodeghiero; Agostino Cortelezzi
Journal:  Clin Cancer Res       Date:  2012-02-09       Impact factor: 12.531

3.  Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia.

Authors:  Anastasia Hadzidimitriou; Nikos Darzentas; Fiona Murray; Tanja Smilevska; Eleni Arvaniti; Cristina Tresoldi; Athanasios Tsaftaris; Nikolaos Laoutaris; Achilles Anagnostopoulos; Frederic Davi; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos; Chrysoula Belessi
Journal:  Blood       Date:  2008-10-23       Impact factor: 22.113

4.  Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2.

Authors:  J C Strefford; L-A Sutton; P Baliakas; A Agathangelidis; J Malčíková; K Plevova; L Scarfó; Z Davis; E Stalika; D Cortese; N Cahill; L B Pedersen; P F di Celle; T Tzenou; C Geisler; P Panagiotidis; A W Langerak; N Chiorazzi; S Pospisilova; D Oscier; F Davi; C Belessi; L Mansouri; P Ghia; K Stamatopoulos; R Rosenquist
Journal:  Leukemia       Date:  2013-04-05       Impact factor: 11.528

5.  No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.

Authors:  Panagiotis Baliakas; Mattias Mattsson; Anastasia Hadzidimitriou; Eva Minga; Andreas Agathangelidis; Lesley-Ann Sutton; Lydia Scarfo; Zadie Davis; Xiao-Jie Yan; Karla Plevova; Yorick Sandberg; Fie J Vojdeman; Tatiana Tzenou; Charles C Chu; Silvio Veronese; Larry Mansouri; Karin E Smedby; Véronique Giudicelli; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Achilles Anagnostopoulos; Marie-Paule Lefranc; Livio Trentin; Mark Catherwood; Marco Montillo; Carsten U Niemann; Anton W Langerak; Sarka Pospisilova; Niki Stavroyianni; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Tait Shanafelt; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Paolo Ghia; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Haematologica       Date:  2017-12-21       Impact factor: 9.941

Review 6.  Stereotyped B Cell Receptor Immunoglobulins in B Cell Lymphomas.

Authors:  Andreas Agathangelidis; Fotis Psomopoulos; Kostas Stamatopoulos
Journal:  Methods Mol Biol       Date:  2019

7.  Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial.

Authors:  Jeffrey A Jones; Tadeusz Robak; Jennifer R Brown; Farrukh T Awan; Xavier Badoux; Steven Coutre; Javier Loscertales; Kerry Taylor; Elisabeth Vandenberghe; Malgorzata Wach; Nina Wagner-Johnston; Loic Ysebaert; Lyndah Dreiling; Ronald Dubowy; Guan Xing; Ian W Flinn; Carolyn Owen
Journal:  Lancet Haematol       Date:  2017-03       Impact factor: 18.959

8.  Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling.

Authors:  Marcus Dühren-von Minden; Rudolf Übelhart; Dunja Schneider; Thomas Wossning; Martina P Bach; Maike Buchner; Daniel Hofmann; Elena Surova; Marie Follo; Fabian Köhler; Hedda Wardemann; Katja Zirlik; Hendrik Veelken; Hassan Jumaa
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

9.  Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.

Authors:  Till Seiler; Manuela Woelfle; Sophia Yancopoulos; Rosa Catera; Wentian Li; Katerina Hatzi; Carol Moreno; Marcela Torres; Santanu Paul; Hartmut Dohner; Stephan Stilgenbauer; Matthew S Kaufman; Jonathan E Kolitz; Steven L Allen; Kanti R Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  Blood       Date:  2009-08-18       Impact factor: 22.113

10.  Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.

Authors:  R Rosenquist; P Ghia; A Hadzidimitriou; L-A Sutton; A Agathangelidis; P Baliakas; N Darzentas; V Giudicelli; M-P Lefranc; A W Langerak; C Belessi; F Davi; K Stamatopoulos
Journal:  Leukemia       Date:  2017-04-25       Impact factor: 11.528

View more
  19 in total

1.  Molecular map of chronic lymphocytic leukemia and its impact on outcome.

Authors:  Binyamin A Knisbacher; Ziao Lin; Cynthia K Hahn; Ferran Nadeu; Martí Duran-Ferrer; Kristen E Stevenson; Eugen Tausch; Julio Delgado; Alex Barbera-Mourelle; Amaro Taylor-Weiner; Pablo Bousquets-Muñoz; Ander Diaz-Navarro; Andrew Dunford; Shankara Anand; Helene Kretzmer; Jesus Gutierrez-Abril; Sara López-Tamargo; Stacey M Fernandes; Clare Sun; Mariela Sivina; Laura Z Rassenti; Christof Schneider; Shuqiang Li; Laxmi Parida; Alexander Meissner; François Aguet; Jan A Burger; Adrian Wiestner; Thomas J Kipps; Jennifer R Brown; Michael Hallek; Chip Stewart; Donna S Neuberg; José I Martín-Subero; Xose S Puente; Stephan Stilgenbauer; Catherine J Wu; Elias Campo; Gad Getz
Journal:  Nat Genet       Date:  2022-08-04       Impact factor: 41.307

2.  Characterizing Features of Human Circulating B Cells Carrying CLL-Like Stereotyped Immunoglobulin Rearrangements.

Authors:  Davide Bagnara; Monica Colombo; Daniele Reverberi; Serena Matis; Rosanna Massara; Niccolò Cardente; Gianluca Ubezio; Vanessa Agostini; Luca Agnelli; Antonino Neri; Martina Cardillo; Stefano Vergani; Fabio Ghiotto; Andrea Nicola Mazzarello; Fortunato Morabito; Giovanna Cutrona; Manlio Ferrarini; Franco Fais
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

3.  Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Authors:  Carmen Stanganelli; Davi Coe Torres; Claudia Ortega; María Elena Márquez; Victoria Remedi; Juana Cabrera; Claudia Mardaraz; Camila Galvano; Andrea Krzywinski; Cecilia Lang; Lorena Zanella; Evangelina Agriello; Raimundo Bezares; Astrid Pavlovsky; Miguel A Pavlovsky; Pablo Oppezzo; Irma Slavutsky
Journal:  Ann Hematol       Date:  2021-10-28       Impact factor: 4.030

Review 4.  T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword.

Authors:  Elisavet Vlachonikola; Kostas Stamatopoulos; Anastasia Chatzidimitriou
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

5.  The Traf2DNxBCL2-tg Mouse Model of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Recapitulates the Biased IGHV Gene Usage, Stereotypy, and Antigen-Specific HCDR3 Selection of Its Human Counterpart.

Authors:  Gema Perez-Chacon; Juan M Zapata
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

6.  The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia.

Authors:  Antonella Nicolò; Alexandra Theresa Linder; Hassan Jumaa; Palash Chandra Maity
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

Review 7.  Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective.

Authors:  Marwan Kwok; Catherine J Wu
Journal:  Front Oncol       Date:  2021-12-16       Impact factor: 6.244

Review 8.  Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway.

Authors:  C I Edvard Smith; Jan A Burger
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

9.  IMGT® databases, related tools and web resources through three main axes of research and development.

Authors:  Taciana Manso; Géraldine Folch; Véronique Giudicelli; Joumana Jabado-Michaloud; Anjana Kushwaha; Viviane Nguefack Ngoune; Maria Georga; Ariadni Papadaki; Chahrazed Debbagh; Perrine Pégorier; Morgane Bertignac; Saida Hadi-Saljoqi; Imène Chentli; Karima Cherouali; Safa Aouinti; Amar El Hamwi; Alexandre Albani; Merouane Elazami Elhassani; Benjamin Viart; Agathe Goret; Anna Tran; Gaoussou Sanou; Maël Rollin; Patrice Duroux; Sofia Kossida
Journal:  Nucleic Acids Res       Date:  2022-01-07       Impact factor: 16.971

Review 10.  Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features.

Authors:  Lina van der Straten; Paul J Hengeveld; Arnon P Kater; Anton W Langerak; Mark-David Levin
Journal:  Front Oncol       Date:  2021-12-09       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.